Goldman Shlomit, Shalev Eliezer
Laboratory for Research in Reproductive Sciences, Department of Obstetrics and Gynecology, Ha'Emek Medical Center, 18101, Afula, Israel.
J Exp Clin Assist Reprod. 2006 Apr 6;3:4. doi: 10.1186/1743-1050-3-4.
Progesterone receptor act as ligand-inducible transcription factor in the respective target cells by binding to specific progesterone response elements in the promoter of the target genes. However, despite the lack of the classical progesterone response elements on matrix-metalloproteinase-2 promoter, progesterone has been shown to decrease the activity of this promoter.
It has recently been suggested that in addition to interacting with their classical co-activators and co-repressors, progesterone receptor are capable of binding to several transcription factors. By interacting with other classes of transcription factors, progesterone receptor is capable of transcriptional activation through the transcription factors cognate DNA binding site.
Exploring transcription factors and transcription binding sites, interacting with the progesterone receptor in modulation of the matrix-metalloproteinase promoter.
Identification of additional endogenous progesterone target genes makes it possible to further explore the signaling mechanisms by which the hormone regulates biological actions. Furthermore, the concepts of ligand-driven conformational diversity and selective tissue actions can be exploited in the future for drug development which selectively regulate orphan receptors from the nuclear receptor family.
孕酮受体通过与靶基因启动子中的特定孕酮反应元件结合,在相应靶细胞中作为配体诱导型转录因子发挥作用。然而,尽管基质金属蛋白酶-2启动子上缺乏经典的孕酮反应元件,但已表明孕酮可降低该启动子的活性。
最近有人提出,除了与经典的共激活因子和共抑制因子相互作用外,孕酮受体还能够与多种转录因子结合。通过与其他类型的转录因子相互作用,孕酮受体能够通过转录因子同源DNA结合位点进行转录激活。
探索与孕酮受体相互作用以调节基质金属蛋白酶启动子的转录因子和转录结合位点。
鉴定额外的内源性孕酮靶基因使得进一步探索该激素调节生物学作用的信号传导机制成为可能。此外,配体驱动的构象多样性和选择性组织作用的概念未来可用于药物开发,以选择性调节核受体家族中的孤儿受体。